Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV734, a small molecule G protein biased ligand of the MOR, which has completed phase I studies for the treatment of moderate-to-severe acute and chronic pain; and TRV045, a novel S1P modulator for managing chronic pain. Trevena, Inc. was incorporated in 2007 and is headquartered in Chesterbrook, Pennsylvania.
Date |
For |
Estimate |
Reported |
Surprise |
surprise % |
2024-05-20 |
2024-03 |
-0.37 |
N/A |
N/A |
N/A |
2024-04-01 |
2023-12 |
-0.52 |
-1.06 |
-0.54 |
-103.85% |
2023-11-14 |
2023-09 |
0 |
-0.57 |
N/A |
N/A |
2023-08-14 |
2023-06 |
-0.45 |
-0.69 |
-0.24 |
-53.33% |
2023-05-15 |
2023-03 |
-0.85 |
-0.81 |
0.04 |
4.71% |
2023-03-30 |
2022-12 |
0 |
-0.73 |
N/A |
N/A |
Date |
Firm |
Action |
From |
To |
2023-05-16 |
JMP Securities |
Upgrade |
Market Outperform |
Market Outperform |
2023-03-30 |
HC Wainwright & Co. |
Upgrade |
|
Buy |
2023-03-30 |
JMP Securities |
Upgrade |
|
Market Outperform |
Date |
Name |
Relation |
Quantity |
Description |
2020-12-16 |
APPLEBAUM SCOTT |
Officer |
365.20K |
Stock Award(Grant) |
2023-12-13 |
BOURDOW CARRIE L |
Chief Executive Officer |
642.92K |
Stock Award(Grant) |
2023-12-13 |
DEMITRACK MARK A |
Officer |
306.22K |
Stock Award(Grant) |
2023-12-13 |
DRAKE PATRICIA M |
Officer |
107.08K |
Stock Award(Grant) |
2019-01-31 |
GOWEN MAXINE |
Chief Executive Officer |
470.01K |
Purchase |
2018-03-21 |
HABIB YACOUB PH.D. |
Officer |
0.00 |
Sale |
Institution Ownership
...
Report Date |
Organization |
Position |
Value |
Percentage |
2023-06-29 |
Renaissance Technologies, LLC |
182.15K |
160.48K |
1.33% |
2023-06-29 |
Blackrock Inc. |
112.17K |
98.82K |
0.82% |
2023-06-29 |
Vanguard Group Inc |
72.81K |
64.15K |
0.53% |
2023-06-29 |
Geode Capital Management, LLC |
65.17K |
57.41K |
0.48% |
2023-06-29 |
Simplex Trading, LLC |
37.59K |
33.12K |
0.27% |
2023-06-29 |
Captrust Financial Advisors |
33.08K |
29.14K |
0.24% |
Report Date |
Organization |
Position |
Value |
Percentage |
2023-06-29 |
Vanguard Extended Market Index Fund |
70.18K |
61.83K |
0.51% |
2023-05-30 |
Fidelity Extended Market Index Fund |
33.10K |
37.73K |
0.24% |
2023-08-30 |
Fidelity OTC Portfolio |
17.81K |
15.49K |
0.13% |
2023-05-30 |
Fidelity Total Market Index Fund |
8.95K |
10.20K |
0.07% |
2023-05-30 |
Fidelity NASDAQ Composite Index Fund |
7.46K |
8.50K |
0.05% |
2023-05-30 |
Fidelity Series Total Market Index Fund |
7.36K |
8.39K |
0.05% |
Split |
Date |
1 : 25 |
2022-11-10 |